Stable Funding and New Originations
Fundings for the quarter totaled $44 million (3 new PE-sponsored investments of $34M plus $10M of add-ons). Since quarter-end the firm funded 2 new portfolio companies totaling $44 million of senior secured debt, supporting modest asset growth.
Healthy Liquidity and Conservative Leverage
Line of credit facility totals $365 million with borrowing availability of more than $150 million at quarter-end. Gross leverage/net debt is around 91.8%/92% of NAV, described as a conservative position to support floating-rate assets.
Net Investment Income and Dividend Coverage
Net investment income was $11.8 million for the quarter (up $574,000 from prior quarter) and represented 116% of cash distributions per common share; monthly distributions for May and June are $0.15 per share (annualized $1.80), producing a yield of about 9.4% at the recent common price.
NAV and Balance Sheet Appreciation
Net assets increased to $483 million (+$5.3 million QoQ) and NAV per share rose from $21.13 to $21.36 (+~1.1%). The net increase in net assets from operations was $15.5 million, or $0.68 per share for the quarter.
Net Portfolio Appreciation Driven by Select Holdings
Net portfolio appreciation of $4.2 million was recorded, largely driven by unrealized appreciation in three larger portfolio companies that continue to scale.
Income Mix and Yield Profile
Weighted average yield on the interest-bearing portfolio remains robust at 11.8% (despite a 40 basis point decline QoQ). Closing spreads on recently completed transactions averaged roughly 7% last quarter.
Lower-Risk Investment Mix and Sector Positioning
First-lien debt comprised ~70% and total debt investments ~90% of portfolio cost. Management highlighted a decline in healthcare concentration, no software exposure (reducing repricing risk), and strong originations demand in precision manufacturing.
Other Income Improvement
Other income was $2.8 million, up $2.2 million QoQ, driven by prepayment fees and a one-time dividend distribution.